Most Recent
Battle to lead AMP action begins, and class members already winners, court told
The showdown between five law firms vying to lead a class action over the AMP fees for no service scandal kicked off in the NSW Supreme Court Thursday with counsel for one case saying the contest, although costly and consuming, would ultimately be a win for all class action participants.
Sacked HWL lawyer’s defence of client criticisms an ‘untenable stretch,’ court hears
Former HWL Ebsworth special counsel Dr Gary Rumble's insistence that he believed he had carte blanche to criticise one of the law firm's clients is an "untenable stretch," the Federal Court heard Wednesday.
B. Braun launches appeal in IV catheter patent case
Medical device maker B. Braun Melsungen is appealing a ruling that invalidated its intravenous catheter patents and dismissed allegations of infringement against rival Becton Dickinson.
Trade mark reputation not a factor in deceptively similar cases: Full Court
A judge applied the "wrong test" when he considered the reputation of a trade mark in an infringement case alleging the marks of rival meat processors were deceptively similar, a Full Federal Court has found.
Wyeth slams Merck Sharp & Dohme’s ‘baseless’ invalidity claim in vaccine trial
Pharmaceutical giant Wyeth has accused Merck Sharp & Dohme of a "baseless" patent invalidity case, saying on the second day of trial over the world's best selling vaccine that the development of its patented Prevnar 13 pneumococcal shot was anything but obvious, as its rival contends.
CBA open to consolidation of dual class actions
The Commonwealth Bank of Australia is open to a proposal to consolidate two shareholder class actions filed over alleged breaches of anti-money laundering and counter-terrorism laws, but will address any "devil in the details", a lawyer for the bank told a court Tuesday.
Merck Sharp & Dohme attacks Wyeth’s ‘broad’ patent claims for Prevnar 13 vaccine
A showdown between global pharmaceutical giants over the world's best selling vaccine began Monday in Federal Court, with Merck Sharp & Dohme claiming three patents for Prevnar 13 sold by Pfizer's Wyeth are invalid and that its own vaccine offers greater protection against pneumococcal bacteria.
Landmark to pay $1M in ACCC case over barley claims
Grain supplier Seednet has agreed to pay $1 million to settle an enforcement action by the consumer watchdog alleging it misled farmers about the performance of its latest barley variety.
ASIC blasted for ‘vague’ case against Tennis Australia duo
A court has told the Australian Securities and Investments Commission to produce more detailed allegations against former Tennis Australia directors Harold Mitchell and Stephen Healy over Seven Network's five-year deal for the broadcast rights to the Australian Open after the regulator was slammed for a vague filing.
AMP admits another possible fees for no service scandal
Embattled wealth manager AMP has revealed its fees for no service scandal could cost the firm more than $1 billion in customer remediation, and that it might be facing another fees scandal.